Metheor Therapeutics' Seed VC Round

Metheor Therapeutics raised a round of funding on August 30, 2011. Investors include Washington Biotechnology Funding.

Metheor Therapeutics focuses on inhibitors of human DNA Methyltransferases (DNMTs). Using rational design methods and medicinal chemistry, the company is working to introduce small molecule compounds …

Articles about Metheor Therapeutics' Seed VC Round: